K183085 is an FDA 510(k) clearance for the CoreDx™ Pulmonary Mini-Forceps. Classified as Bronchoscope (flexible Or Rigid) (product code EOQ), Class II - Special Controls.
Submitted by Boston Scientific Corporation (Marlboro, US). The FDA issued a Cleared decision on March 8, 2019 after a review of 122 days - within the typical 510(k) review window.
This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 874.4680 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.
View all Boston Scientific Corporation devices